Enhanced anti-tumor therapeutic efficacy of DNA vaccine by fusing the E7 gene to BAFF in treating human papillomavirus-associated cancer.
about
Expanded strain coverage for a highly successful public health tool: prophylactic 9-valent human papillomavirus vaccine.Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model.Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.Trial watch: DNA-based vaccines for oncological indications
P2860
Enhanced anti-tumor therapeutic efficacy of DNA vaccine by fusing the E7 gene to BAFF in treating human papillomavirus-associated cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Enhanced anti-tumor therapeuti ...... illomavirus-associated cancer.
@ast
Enhanced anti-tumor therapeuti ...... illomavirus-associated cancer.
@en
type
label
Enhanced anti-tumor therapeuti ...... illomavirus-associated cancer.
@ast
Enhanced anti-tumor therapeuti ...... illomavirus-associated cancer.
@en
prefLabel
Enhanced anti-tumor therapeuti ...... illomavirus-associated cancer.
@ast
Enhanced anti-tumor therapeuti ...... illomavirus-associated cancer.
@en
P2093
P2860
P356
P1433
P1476
Enhanced anti-tumor therapeuti ...... illomavirus-associated cancer.
@en
P2093
C Allen Chang
Chao-Chih Wu
Chih-Long Chang
Fang-Cih Wu
Yu-Chia Hsiao
Yuh-Cheng Yang
Yun-Tin Hsu
P2860
P304
33024-33036
P356
10.18632/ONCOTARGET.16032
P407
P577
2017-03-09T00:00:00Z